Works in Hematological Oncology, 2019, Vol 37, Issue 5
Results: 21
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pediatric-type follicular lymphoma-Complete metabolic remission with radiation therapy.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2019
- By:
- Publication type:
- Letter
The influence of different intensity of treatment on hormonal markers of gonadal function in acute lymphoblastic leukemia survivors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
m7FLIPI and targeted sequencing in high-risk follicular lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter?
- Published in:
- 2019
- By:
- Publication type:
- Letter
Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Current understanding of tumor lysis syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2019, v. 37, n. 5, p. 644, doi. 10.1002/hon.2661
- By:
- Publication type:
- Article
Spontaneous remission of follicular lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Induction therapy in acute myeloid leukemia: Is it time to put aside standard 3 + 7?
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Issue Information.
- Published in:
- Hematological Oncology, 2019, v. 37, n. 5, p. 535, doi. 10.1002/hon.2531
- Publication type:
- Article